Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1/2 1

Status

Completed 4

Sponsor Class

OTHER 3FED 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 26Gastrointestinal 7Gynecologic 5Tumor-Agnostic 4Thoracic 4Other hematologic neoplasm 3Genitourinary 3CNS 3Sarcoma 2Other 2Lymphoid 2Head & Neck 2Endocrine 2Other solid neoplasm 1

Conditions

Neoplasms 4

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Yoga × Tumor-Agnostic × Clear all
NCT07165600 2026-06-04

Yoga to Improve Disparities in Cancer Survivorship

University of California, San Francisco

Phase NA Completed
13 enrolled
Tumor-Agnostic

Neoplasms

NCT04301050 2021-01-13

LYNC

Northwestern University

Phase NA Completed
21 enrolled
Tumor-Agnostic

Neoplasms

NCT02899117 2017-02-17

Yoga Intervention to Improve Pediatric Cancer Patients' Sleep & Life Quality and Parents' Well-Being

Connecticut Children's Medical Center

Phase NA Completed
23 enrolled
Tumor-Agnostic

Neoplasms

NCT01324102 2016-01-01

YogaCares

VA Office of Research and Development

Phase 1/2 Completed
23 enrolled 6 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡